Lmod3 promotes myoblast differentiation and proliferation via the AKT and ERK pathways

Fei-Hu Lin,Anmin Wang,Wuhou Dai,Song Chen,Yahui Ding,Ling V. Sun
DOI: https://doi.org/10.1016/j.yexcr.2020.112297
IF: 4.145
2020-11-01
Experimental Cell Research
Abstract:<p>Mutations in the <em>Lmod3</em> gene have been identified as a genetic cause of nemaline myopathy. However, the mechanism underlying this disease and the function of <em>Lmod3</em> remain largely unknown. In this study, we found that <em>Lmod3</em> knockdown in C2C12 cells impaired myoblast differentiation, whereas enforced <em>Lmod3</em> expression enhanced such differentiation. We also discovered that myoblast proliferation was promoted by <em>Lmod3</em> overexpression but impeded by its knockdown. Additionally, knockdown of <em>Lmod3</em> led to apoptosis in myoblasts. Concurrently, forced <em>Lmod3</em> expression in C2C12 cells contributed to activation of the AKT and ERK pathways during myoblast differentiation and proliferation, respectively. Conversely, knockdown of <em>Lmod3</em> in C2C12 cells produced the opposite results. Furthermore, administration of IGF-1, a booster of both AKT and ERK pathways, partially rescued the inhibitory effect of <em>Lmod3</em> knockdown on both differentiation and proliferation of C2C12 cells. These results suggest that <em>Lmod3</em> promotes differentiation and proliferation of myoblasts through the AKT and ERK pathways, respectively.</p>
oncology,cell biology
What problem does this paper attempt to address?